{"id":"W3092609933","doi":"10.1186/s12931-020-01526-6","title":"NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma","year":2020,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; Amgen","keywords":"Medicine; Asthma; Clinical endpoint; Placebo; Exacerbation; Randomized controlled trial; Population; Thymic stromal lymphopoietin; Quality of life (healthcare); Internal medicine; Pediatrics; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005222513,0.0004585739,0.002004686,0.0003951427,0.0002842392,0.00008626378,0.000320097,0.0002083717,0.00005849395],"category_scores_gemma":[0.00252008,0.0002608232,0.0002419641,0.0009003059,0.0008182547,0.0001460032,0.0002598651,0.0009698934,0.00002665768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001093087,"about_ca_system_score_gemma":0.0007583098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006511531,"about_ca_topic_score_gemma":0.00009187629,"domain_scores_codex":[0.9924414,0.002775631,0.001228516,0.0009215684,0.00180004,0.0008328647],"domain_scores_gemma":[0.9959413,0.001544899,0.0002155905,0.0005850877,0.0005500968,0.001163055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9847085,0.001285704,0.002227661,0.0005219607,0.0002873077,0.0001961467,0.001162268,0.0001051953,0.0004704247,0.00004223,0.0001412268,0.008851361],"study_design_scores_gemma":[0.9853923,0.00683259,0.001048326,0.001499899,0.0002245253,0.00001238566,0.0008795959,0.001909251,0.00008500207,0.000005003351,0.001832143,0.0002790087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9709181,0.003917258,0.0000560864,0.001129355,0.00004841587,0.02354125,0.00002523837,0.00004011882,0.0003242306],"genre_scores_gemma":[0.997207,0.0001518134,0.00005500403,0.0008870318,0.0003607103,0.00122662,0.000007645974,0.00006276021,0.00004141487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02628895,"threshold_uncertainty_score":0.9999844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05276660866435836,"score_gpt":0.3750711105603604,"score_spread":0.3223045018960021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}